Page 30 - Human Use News Today

Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial ELREXFIO is an off-the-shelf ,...

08.12.2023 - Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO (elranatamab). ELREFXIO is a targeted immunotherapy for the treatment of adult patients with relapsed and refractory ...

Pfizer has announced that the European Commission has granted a conditional marketing authorization for Elrexfio , an immunotherapy for adult patients with relapsed and refractory multiple myeloma ...

A new study claims to reveal how the hormone pregnancy test drug Primodos damages the foetus in some pregnant women.

Realignment focused on supporting ONS-5010 U.S. and EU regulatory and commercial prioritiesContinued progress toward commencement of additional adequate and well-controlled study to support the...

By Stephen Nakrosis PTC Therapeutics on Tuesday offered an update on regulatory activities regarding its Translarna protein restoration therapy in both the U.S. and Europe. After the bell,...

By Stephen Nakrosis PTC Therapeutics on Tuesday offered an update on regulatory activities regarding its Translarna protein restoration therapy in both the...

UCB announces European Commission approval of ZILBRYSQ®▼ (zilucoplan) for the treatment of adults with generalized Myasthenia GravisEuropean approval of ZILBRYSQ® (zilucoplan) granted as an add-on to standard therapy for the treatment of generalized Myasthenia Gravis (gMG) in adult patients who are anti-acet...

In this article, we will list and explore the 18 hardest countries to get citizenship in 2023.

Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the...